Current Firm
Cantos
Investments
1+ companies
Focus
Biotech, Climate
Ian Rountree is a venture capital investor at Cantos who positions himself as a "first-check" investor backing founders before they have traction, focusing on what he calls "near frontier" technologies where science is just becoming commercially possible in areas like climate, defense, and industrial resilience. He advocates for "full-stack deep tech" approaches where startups integrate hardware, software, and services rather than just being component suppliers, and hosts the "Near Frontier" podcast to deeply engage with founders building technically challenging, physically instantiated projects.
Ian Rountree is a Founder and General Partner, Cantos at Cantos.
Ian's investment focus spans Biotech, Climate, Deeptech, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments in Ian's portfolio include Astranis. These companies reflect a pattern of backing high-potential startups across their focus sectors.
Ian Rountree is a Founder and General Partner, Cantos at Cantos. Their investment focus includes Biotech, Climate, Deeptech.
Ian Rountree focuses on investments in Biotech, Climate, Deeptech through Cantos. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Ian Rountree's notable portfolio investments include Astranis. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Ian Rountree is currently at Cantos, serving as Founder and General Partner, Cantos.